SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

Net Asset Value(s)

18 Sep 2014 07:00

RNS Number : 9714R
J.P. Morgan Private Equity Ltd
18 September 2014
Β 

J.P. Morgan Private Equity Limited

PO Box 60

Carinthia House

9-12 The Grange

St Peter Port

Guernsey GY1 4BF

www.jpelonline.com, www.jpelonline.co.uk

Β 

Regulatory News Service

London Stock Exchange

London

EC2N 1HP

Β 

Β 

18 September 2014

Β 

Β 

Notice to Shareholders - Net Asset Value and Month End Review for July 2014

Β 

J.P. Morgan Private Equity Limited ("JPEL" or the "Company") has released the Company's Net Asset Value and Month End Review for the period ending 31 July 2014.

Β 

Please find detailed below the estimated net asset value per share for J.P. Morgan Private Equity Limited as at 31 July 2014*:

Ordinary Share Class (Fully Diluted) - $1.13

Zero Dividend Preference Share Class due 2015 - 78.50p

Zero Dividend Preference Share Class due 2017 - 82.20p

Β 

Shareholders may access an electronic copy of the Monthly Report at www.jpelonline.com or www.jpelonline.co.uk by clicking the "Investor Information" link on the home page and then clicking the "Reports" link. An electronic copy of the Monthly Report is also attached to this notice.

Click on, or paste the following link into your web browser to view the associated PDF document:

Β http://www.rns-pdf.londonstockexchange.com/rns/9714R_-2014-9-17.pdf

Β 

*As at 31 July 2014, the Ordinary Share Class net asset value does not materially differ on a basic or fully diluted basis.

Β 

This is an estimated valuation of the net assets of the Company as at 31 July 2014. This valuation is for information purposes only and has not been verified by the Company or the Manager. This valuation includes the most recent information available from the Company's underlying private equity fund managers for their respective private equity portfolios. It is based on unaudited estimated valuations supplied by the administrators, managers, or investment advisers of the Company's underlying investments. Whilst the Manager believes this information to be useful investor information, it is subject to material change and consequently no reliance should be placed as to its accuracy.

Β 

Neither the Company nor the Manager accept any liability whatsoever in regard to this information. The only official valuation of the Company's portfolio is the valuation produced as at the last business day of each month and reported via RNS when released.

Β 

Β 

Β 

* * *

Β 

About J.P. Morgan Private Equity Limited

Β 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

Β 

Β 

ENQUIRIES:

Β 

Bear Stearns Asset Management

JP Morgan Asset Management (UK) Limited

JF International Management Inc.

Β 

Β 

Troy Duncan / Greg Getschow

Troy.Duncan@jpmorgan.com / Gregory.Getschow@jpmorgan.com

Β 

Rosemary DeRise / Samantha Ladd

+1 212 648 2980 / +1 212 648 2982

Rosemary.DeRise@jpmorgan.com / Samantha.Ladd@jpmorgan.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
NAVDDLFFZKFZBBL
Date   Source Headline
2nd Jun 20269:29 amRNSNet Asset Value - March 2026
23rd Apr 20267:00 amRNSJoint Broker Appointment
14th Apr 20267:00 amRNSAppointment of Directors
6th Mar 20265:59 pmRNSHalf-year Financial Report - December 2025
14th Jan 20269:53 amRNSCOMPLETION OF THIRTEENTH MANDATORY REDEMPTION
29th Dec 20253:18 pmRNSTHIRTEENTH MANDATORY REDEMPTION
19th Dec 20255:53 pmRNSNet Asset Value September 2025
2nd Dec 20254:44 pmRNS2025 AGM Results Statement
10th Nov 202512:19 pmRNS2025 AGM Circular Statement
5th Nov 20254:07 pmRNSHolding(s) in Company
3rd Nov 20254:30 pmRNSHolding(s) in Company
3rd Nov 20254:11 pmRNSHolding(s) in Company
30th Oct 20257:00 amRNSAnnual Financial Report 2025
22nd Jul 20257:00 amRNSAppointed Sole Corp. Broker & Financial Adviser
10th Jun 20254:47 pmRNSNet Asset Value - March 2025
1st May 20256:11 pmRNSHolding(s) in Company
18th Mar 20255:04 pmRNSHalf-year Report - December 2024
3rd Dec 20242:30 pmRNSNet Asset Value September 2024
27th Nov 20245:16 pmRNS2024 AGM Results
6th Nov 20247:00 amRNS2024 AGM Circular
25th Oct 20247:00 amRNSPortfolio Update
25th Oct 20247:00 amRNSAnnual Financial Report - 2024
5th Jun 20247:00 amRNSNet Asset Value - March 2024
23rd Apr 20245:18 pmRNSDirector Declaration
15th Mar 20246:15 pmRNSNet Asset Value - December 2023
15th Mar 20246:03 pmRNSHalf-year Report - December 2023
15th Mar 20243:50 pmRNSHalf-year Report - 2023
6th Dec 20235:36 pmRNSDirector Declaration
6th Dec 20235:33 pmRNSAGM RESULTS 2023
9th Nov 202311:56 amRNS2023 AGM CIRCULAR
8th Nov 20237:00 amRNSCompletion of Twelfth Mandatory Redemption
24th Oct 20237:00 amRNSTwelfth Mandatory Redemption & Shareholder Update
20th Oct 202310:28 amRNSNet Asset Value - September 2023
21st Sep 20235:33 pmRNSNet Asset Value(s) - June 2023
21st Jun 20233:36 pmRNSDirectorate Change
12th May 20231:46 pmRNSNet Asset Value(s) - March 2023
28th Mar 20233:32 pmRNSHalf-year Report - 31 December 2022
14th Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 202311:05 amRNSSecond Price Monitoring Extn
14th Mar 202311:00 amRNSPrice Monitoring Extension
14th Mar 20239:05 amRNSSecond Price Monitoring Extn
14th Mar 20239:00 amRNSPrice Monitoring Extension
24th Feb 20234:22 pmRNSNet Asset Value(s) - December 2022
13th Feb 20234:51 pmRNSDirector Declaration
22nd Dec 20227:00 amRNSCompletion of Eleventh Mandatory Redemption
14th Dec 20227:00 amRNSELEVENTH MANDATORY REDEMPTION & SHAREHOLDER UPDATE
13th Dec 20225:09 pmRNSDirectorate Change
29th Nov 20224:33 pmRNSAGM Results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.